5Beauchamp RL,Banwell A,McNamara P, et al.Exon scanning of the entire TSC2 gene for germline mutations in 40 unrelated patients with tuberous sclerosis[J].Hum Mutat, 1998,12(6):408-416.
6Noonan DJ,Lou D,Griffith N,et al.A calmodulin binding site in the tuberous sclerosis 2 gene product is essential for regulation of transcription events and is altered by mutations linked to tuberouss clerosis and lymphangioleiomyomatosis[J].Areh Biochem Biophys, 2002,398(1):132-140.
7Dabora SL,Jozwiak S,Franz DN,et al.Mutational analysis in acohort of 224 tuberous sclerosis patients indicates increased severity of TSC2.compared with TSCl.disease in multiple organs[J].Am Hum Genet,2001,68(3):64-80.
8Zhao XY, Yang S,Zhang XJ,et al.Two novel TSC2 mutations in Chinese patients with tuberous sclerosis complex and a literature review of 20 patients reported in China[J].Br J Dermatol,2006,155 (5):1070-1073.
9Van SM,Hoogt R,Hermans C,et al .Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34 [J] .Science,1997,277 (5327):805-808.
10Jones AC,Daniells CE,Snell RG,et al .Molecular genetic and phenotypic analysis reveals differences between TSC1 and TSC2 associated familial and sporadic tuberous sclerosis[J] .Hum Mol Genet,1997,6(12) :2155-2161.
二级参考文献11
1The European chromosome16 sclerosis consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993;75:1305 - 1315.
2Van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997 ; 277 : 805 - 808.
3Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci 1991;615:125- 127.
5Krymskaya VP. Tumour suppressors hamartin and tuberin: intracellular sigrkalling. Cell Signal 2003;15:729- 739.
6Jones AC, Shyamsundar MM, Thomas MW, et al. Comprehensive mutation analysis of TSC1 and TSC2 - and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 1999;64(5) : 1305- 1315.
7Rose VM, Au KS, Pollom G, et al. Germ- Line mosaicism in tuberous sclerosis: how common. Hum Genet 1999;64:986- 992.
8Beauchamp RL, Banwell A, McNamara P, et al. Exon scanning of the entire TSC2 gene for gennline mutations in 40 unrelated patients with tuberous sclerosis. Hum Mutat 1998; 12(6) :408 - 416.
9Noonan DJ, kou D, Griffith N, et al. A calmodulin binding site inthe tuberous sclerosis 2 gene product is essential for regulation of-transcription events and is altered by mutations linked to tuberoussclerosis and lymphangioleiomyomatosis. Arch Biochem Biophys 2002;398:132 - 140.
10Dabora SL, Jozwiak S, Franz DN, et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001 ;68:64 - 80.
